Matthew Rabinowitz net worth and biography

Matthew Rabinowitz Biography and Net Worth

Chairman of Natera
Matthew Rabinowitz is a co-founder of our company and currently serves as our Executive Chairman. Dr. Rabinowitz served as our Chief Executive Officer from 2005 to January 2019 and served as a member of our board of directors since 2005. He served as Chairman of our board of directors from May 2015 to January 2019, at which time he assumed the role of Executive Chairman. Prior to co-founding our company, Dr. Rabinowitz served from 2000 to 2003 as chief executive officer and from 2003 to 2007 as chief technology officer of Rosum Corporation, a location services technology company. Dr. Rabinowitz served as a consulting professor at Stanford University from 2004 to 2012 and as visiting faculty in the Genetics Department of Harvard University from 2018 to 2019. Dr. Rabinowitz has over 100 patents and publications in signal processing, machine learning, bio-informatics, and high-throughput genetic testing. He received the Scott Helt Memorial Award from the Institute of Electrical and Electronics Engineers and has twice received the Technology Pioneer Award from the World Economic Forum. He currently serves as a member of the board of directors or advisory board of a number of technology companies. Dr. Rabinowitz holds a Bachelor of Science degree in Engineering and Physics, a Master of Science in Electrical Engineering, and a Ph.D. in Electrical Engineering, from Stanford University.

What is Matthew Rabinowitz's net worth?

The estimated net worth of Matthew Rabinowitz is at least $28.01 million as of January 3rd, 2023. Dr. Rabinowitz owns 639,803 shares of Natera stock worth more than $28,010,575 as of February 6th. This net worth evaluation does not reflect any other assets that Dr. Rabinowitz may own. Learn More about Matthew Rabinowitz's net worth.

What is Matthew Rabinowitz's salary?

As the Chairman of Natera, Inc., Dr. Rabinowitz earned a total compensation package of $10,129,121.00 in 2021. Dr. Rabinowitz earned a salary of $334,002.00, options awards of $9,626,909.00, non-equity compensation of $168,210.00, and no other miscellaneous compensation. Learn More on Matthew Rabinowitz's salary.

How do I contact Matthew Rabinowitz?

The corporate mailing address for Dr. Rabinowitz and other Natera executives is 201 INDUSTRIAL ROAD SUITE 410, SAN CARLOS CA, 94070. Natera can also be reached via phone at (650) 249-9090 and via email at [email protected] Learn More on Matthew Rabinowitz's contact information.

Has Matthew Rabinowitz been buying or selling shares of Natera?

During the last quarter, Matthew Rabinowitz has sold $107,022.30 in Natera stock. Most recently, Matthew Rabinowitz sold 2,706 shares of the business's stock in a transaction on Tuesday, January 3rd. The shares were sold at an average price of $39.55, for a transaction totalling $107,022.30. Following the completion of the sale, the chairman now directly owns 639,803 shares of the company's stock, valued at $25,304,208.65. Learn More on Matthew Rabinowitz's trading history.

Who are Natera's active insiders?

Natera's insider roster includes Roy Baynes (Director), Roelof Botha (Director), Michael Brophy (CFO), Rowan Chapman (Director), Steven Chapman (CEO), Todd Cozzens (Director), James Healy (Director), Gail Marcus (Director), Daniel Rabinowitz (Insider), Matthew Rabinowitz (Chairman), Herm Rosenman (Director), Robert Schueren (COO), and Jonathan Sheena (Insider). Learn More on Natera's active insiders.

Are insiders buying or selling shares of Natera?

During the last twelve months, Natera insiders bought shares 2 times. They purchased a total of 372,820 shares worth more than $11,323,786.80. During the last twelve months, insiders at the medical research company sold shares 62 times. They sold a total of 164,110 shares worth more than $6,807,068.72. The most recent insider tranaction occured on February, 1st when CFO Michael Burkes Brophy sold 19,326 shares worth more than $844,159.68. Insiders at Natera own 10.3% of the company. Learn More about insider trades at Natera.

Information on this page was last updated on 2/1/2023.

Matthew Rabinowitz Insider Trading History at Natera

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/3/2023Sell2,706$39.55$107,022.30639,803View SEC Filing Icon  
5/12/2022Buy219,820$28.74$6,317,626.80420,000View SEC Filing Icon  
10/14/2021Sell122$112.19$13,687.18View SEC Filing Icon  
9/23/2021Sell159$125.67$19,981.53View SEC Filing Icon  
9/10/2021Sell876$119.53$104,708.28View SEC Filing Icon  
7/14/2021Sell76$116.20$8,831.20580,202View SEC Filing Icon  
6/23/2021Sell99$115.18$11,402.82579,994View SEC Filing Icon  
6/10/2021Sell698$102.60$71,614.80580,292View SEC Filing Icon  
4/14/2021Sell76$108.54$8,249.04577,550View SEC Filing Icon  
3/23/2021Sell101$101.72$10,273.72577,344View SEC Filing Icon  
3/10/2021Sell766$97.31$74,539.46577,709View SEC Filing Icon  
2/1/2021Sell212$107.40$22,768.80574,703View SEC Filing Icon  
12/10/2020Sell996$92.59$92,219.64575,392View SEC Filing Icon  
11/11/2020Sell70,000$77.86$5,450,200.00572,574View SEC Filing Icon  
11/9/2020Sell90,000$81.31$7,317,900.00572,574View SEC Filing Icon  
10/14/2020Sell108$73.45$7,932.60572,682View SEC Filing Icon  
10/7/2020Sell250,000$71.62$17,905,000.00View SEC Filing Icon  
10/5/2020Sell90,000$70.50$6,345,000.00View SEC Filing Icon  
9/23/2020Sell141$63.31$8,926.71572,516View SEC Filing Icon  
9/10/2020Sell1,014$60.77$61,620.78View SEC Filing Icon  
7/14/2020Sell108$45.98$4,965.84View SEC Filing Icon  
6/23/2020Sell142$45.51$6,462.421,109,947View SEC Filing Icon  
6/15/2020Sell976$41.90$40,894.401,109,547View SEC Filing Icon  
3/23/2020Sell579$24.09$13,948.111,108,284View SEC Filing Icon  
3/10/2020Sell1,107$33.36$36,929.521,104,973View SEC Filing Icon  
1/14/2020Sell127$33.48$4,251.961,205,100View SEC Filing Icon  
12/18/2019Sell16,856$35.60$600,073.601,259,461View SEC Filing Icon  
12/16/2019Sell33,333$37.73$1,257,654.091,259,461View SEC Filing Icon  
10/14/2019Sell148$38.20$5,653.601,287,054View SEC Filing Icon  
9/10/2019Sell1,417$29.50$41,801.501,288,164View SEC Filing Icon  
7/15/2019Sell154$25.84$3,979.361,285,500View SEC Filing Icon  
6/10/2019Sell1,418$24.79$35,152.221,286,612View SEC Filing Icon  
4/15/2019Sell614$20.25$12,433.501,284,408View SEC Filing Icon  
3/11/2019Sell5,672$16.00$90,752.001,288,853View SEC Filing Icon  
9/26/2018Sell324,844$24.85$8,072,373.40982,442View SEC Filing Icon  
9/24/2018Sell35,845$23.98$859,563.10982,442View SEC Filing Icon  
9/21/2018Sell212,001$23.88$5,062,583.881,170,073View SEC Filing Icon  
9/18/2018Sell251,699$24.17$6,083,564.831,443,558View SEC Filing Icon  
9/13/2018Sell403,462$24.90$10,046,203.801,701,686View SEC Filing Icon  
9/11/2018Sell185,163$25.13$4,653,146.191,701,686View SEC Filing Icon  
12/5/2016Sell14,021$12.02$168,532.421,888,644View SEC Filing Icon  
12/1/2016Sell56,072$12.01$673,424.721,942,572View SEC Filing Icon  
11/28/2016Sell146,756$12.50$1,834,450.002,020,876View SEC Filing Icon  
7/1/2016Sell104,892$12.14$1,273,388.882,167,354View SEC Filing Icon  
6/19/2016Sell732,831$11.94$8,750,002.142,876,595View SEC Filing Icon  
1/5/2016Sell54,683$10.37$567,062.712,762,777View SEC Filing Icon  
12/31/2015Sell111,513$10.83$1,207,685.792,817,460View SEC Filing Icon  
12/29/2015Sell83,804$10.62$889,998.482,928,973View SEC Filing Icon  
See Full Table

Matthew Rabinowitz Buying and Selling Activity at Natera

This chart shows Matthew Rabinowitz's buying and selling at Natera by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Natera Company Overview

Natera logo
Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. It provides Panorama non-invasive prenatal test (NIPT), Vistara, horizon carrier screening (HCS), spectrum pre-implantation genetic screening and spectrum pre-implantation genetic diagnosis, Anora products of conception (POC) and non-invasive paternity testing (PAT). The firm also offers Constellation, a cloud-based software product that allows laboratory customers to gain access to the algorithms and bioinformatics in order to validate and launch tests based on the technology. The company was founded by Matthew Rabinowitz and Jonathan Sheena in November 2003 and is headquartered in Austin, TX.
Read More

Today's Range

Now: $43.78
Low: $43.32
High: $44.76

50 Day Range

MA: $40.71
Low: $36.57
High: $46.55

2 Week Range

Now: $43.78
Low: $26.10
High: $74.82


586,164 shs

Average Volume

1,361,928 shs

Market Capitalization

$4.27 billion

P/E Ratio


Dividend Yield